These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8984083)

  • 1. Calcium channel blockers in the management of hypertension.
    Fitzgerald D
    Ir Med J; 1996; 89(1):8. PubMed ID: 8984083
    [No Abstract]   [Full Text] [Related]  

  • 2. ALLHAT and calcium channel blockers. ALLHAT Research Group.
    Proschan M; Davis B; Cutler J; Ford C; Furberg C; Grimm R; Oparil S
    Am J Hypertens; 1997 Jan; 10(1):142-3. PubMed ID: 9008261
    [No Abstract]   [Full Text] [Related]  

  • 3. Do calcium channel blockers increase the risk of myocardial infarction in hypertensive patients with diabetes mellitus?
    Park L; Por CP; Evans MF
    Can Fam Physician; 1998 Nov; 44():2405-7. PubMed ID: 9839057
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hypertension with calcium antagonists and increased risk of acute myocardial infarction: reliable results?].
    Jensen G
    Ugeskr Laeger; 1995 Oct; 157(41):5732. PubMed ID: 7571114
    [No Abstract]   [Full Text] [Related]  

  • 6. From the LSMS Committee on Chronic Diseases. Recent media reports of potential risks from calcium antagonists.
    Frohlich ED
    J La State Med Soc; 1995 Aug; 147(8):343. PubMed ID: 7673778
    [No Abstract]   [Full Text] [Related]  

  • 7. Enough to raise one's blood pressure.
    Meyer CR
    Minn Med; 1995 May; 78(5):2. PubMed ID: 7791723
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renewed discussion on calcium antagonists in hypertension. More myocardial infarcts?].
    Einecke D
    MMW Fortschr Med; 2000 Sep; 142(37):8-9. PubMed ID: 11026215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term treatment with calcium antagonists: advantageous effects and risks].
    van Zwieten PA; Tijssen JG; Lie KI; de Leeuw PW
    Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2715-21. PubMed ID: 8569884
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium channel blockers and myocardial infarction.
    Smith GN
    J Fam Pract; 1996 Jan; 42(1):30-2. PubMed ID: 8537801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 12. The calcium channel blocker controversy - a caution to physicians and pharmacist.
    Eliot L
    J Pharm Pharm Sci; 1998; 1(1):13-4. PubMed ID: 10942968
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium channel blockers, risk of cancer, and the challenge of assessing medication safety.
    Pahor M
    Tenn Med; 1997 Sep; 90(9):367-9. PubMed ID: 9308392
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium channel blockers in perspective.
    Harv Heart Lett; 1998 Aug; 8(12):1-3. PubMed ID: 9713233
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of calcium channel blockers for hypertension questioned.
    Health News; 2005 Apr; 11(4):5. PubMed ID: 15818763
    [No Abstract]   [Full Text] [Related]  

  • 16. [There is no reason to avoid calcium antagonists in hypertension].
    Hansson L; Hansson BG; Hedner T
    Lakartidningen; 1996 Aug; 93(35):2918. PubMed ID: 8815344
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium channel blockers in the treatment of hypertension and ischemic coronary disease. Conflicts in their evaluation].
    Mayer O
    Cas Lek Cesk; 1998 Apr; 137(7):216-9. PubMed ID: 9650344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pressure's on. A hypertension drug taken by 28 million people is under scrutiny. What are the other options?
    Smith IK
    Time; 2000 Sep; 156(11):126. PubMed ID: 11067229
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of calcium-channel blockers.
    Med Lett Drugs Ther; 1997 Feb; 39(994):13-4. PubMed ID: 9040648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.